EDIT vs TWLO · rev $32.3M vs P/E 1087, rev $4.46B
Editas Medicine Inc (EDIT) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported TWLO revenue for 2024-12-31 was $4.46B. Net income was -$109.4M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
EDIT currently screens at market cap $375.2M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the EDIT and TWLO stock pages for the full models.
Not investment advice.